Modulation of total Akt kinase by increased expression of a single isoform: Requirement of the sphingosine-1-phosphate receptor, Edg3/S1P3, for the VEGF-dependent expression of Akt3 in primary endothelial cells

被引:28
作者
Fieber, CB
Eldridge, J
Taha, TA
Obeid, LM
Muise-Helmericks, RC
机构
[1] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Ralph H Johnson Vet Adm, Charleston, SC 29425 USA
[3] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
[4] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA
关键词
D O I
10.1016/j.yexcr.2006.01.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Akt kinase is an important downstream effector of VEGF in primary endothelial cells (EC), promoting angiogenesis by increased cellular survival, motility and tubulogenesis. Akt1 is the founding member of a family of serine threonine kinases thought to have overlapping function. We sought to determine if other Akt family members were also regulated by VEGF in EC. We show that treatment of EC with the angiogenic inducers VEGF or sphingosine-1-phosphate (SIP) results in an increased stabilization of Akt3 mRNA, concur-rent with a PI3 kinase-dependent, Akt1-independent increase in both the protein and its phosphorylation. Given the similarity of Akt3 regulation by VEGF and S1P, the sensitivity of VEGF stimulation to the Gi-protein uncoupling reagent, pertussis toxin was tested and shows that VEGF stimulation requires Gi-protein signaling. We show that the VEGF stimulates the expression of Edg3/S1P3 (S1P3) and that expression of this Gi-protein-coupled receptor is both sufficient and necessary for the expression of Akt3. Blockade of a single isoform. does not overtly affect cellular function, whereas inhibition of both kinases results in an increase in apoptosis and a down-regulation of cyclin D3. These results suggest a model whereby extracellular cues maintain total Akt kinase levels through the regulation of specific isoform expression providing a fail-safe mechanism to maintain necessary levels of Akt kinase activity. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1164 / 1173
页数:10
相关论文
共 49 条
[1]   Protective role of endothelial nitric oxide synthase [J].
Albrecht, EWJA ;
Stegeman, CA ;
Heeringa, P ;
Henning, RH ;
van Goor, H .
JOURNAL OF PATHOLOGY, 2003, 199 (01) :8-17
[2]  
Bloor BK, 2002, INT J ONCOL, V21, P907
[3]   A TARGET FOR PHOSPHOINOSITIDE 3-KINASE - AKT/PKB [J].
BOS, JL .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (11) :441-442
[4]   Ten years of protein kinase B signalling: a hard Akt to follow [J].
Brazil, DP ;
Hemmings, BA .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (11) :657-664
[5]  
Carón RW, 2005, MOL CANCER THER, V4, P257
[6]   Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy [J].
Chang, F ;
Lee, JT ;
Navolanic, PM ;
Steelman, LS ;
Shelton, JG ;
Blalock, WL ;
Franklin, RA ;
McCubrey, JA .
LEUKEMIA, 2003, 17 (03) :590-603
[7]  
Chang-Liao KS, 2001, ELEC SOC S, V2001, P1
[8]   AKT2, A PUTATIVE ONCOGENE ENCODING A MEMBER OF A SUBFAMILY OF PROTEIN-SERINE THREONINE KINASES, IS AMPLIFIED IN HUMAN OVARIAN CARCINOMAS [J].
CHENG, JQ ;
GODWIN, AK ;
BELLACOSA, A ;
TAGUCHI, T ;
FRANKE, TF ;
HAMILTON, TC ;
TSICHLIS, PN ;
TESTA, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :9267-9271
[9]   Amplification of AKT2 in human pancreatic cancer cells and inhibition of ATK2 expression and tumorigenicity by antisense RNA [J].
Cheng, JQ ;
Ruggeri, B ;
Klein, WM ;
Sonoda, G ;
Altomare, DA ;
Watson, DK ;
Testa, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3636-3641
[10]   Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway [J].
DeBusk, LM ;
Hallahan, DE ;
Lin, PC .
EXPERIMENTAL CELL RESEARCH, 2004, 298 (01) :167-177